Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Anthracycline-containing combination used as primary chemotherapy results
November 10th, 2005
Anthracycline-containing combination used as primary chemotherapy in premenopausal patients results in long-term effects. "The role of anthracyclines has been extensively studied in adjuvant chemotherapy, but much less in the primary chemotherapy of early breast carcinoma." According to recent research from Italy, "a study, comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with the rotational anthracycline-containing regimen CMFEV (CMF plus epirubicin and vincristine) administered as primary chemotherapy, demonstrated a significant increase in clinical complete response in premenopausal women." G. Cocconi and colleagues reported "the...
Source: Women's Health Weekly (2005-11-10)
|
